-
Mashup Score: 0
/PRNewswire/ — Invitae (OTC:NVTA), a leading medical genetics company, announced that Labcorp (NYSE: LH), a global leader of innovative and comprehensive…
Source: www.prnewswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 33Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis - 5 day(s) ago
− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg)…
Source: www.prnewswire.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
/PRNewswire/ — With every successive year, the lines between medical devices and consumer electronics become increasingly blurred – medtech companies seek to…
Source: www.prnewswire.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
/PRNewswire/ — VieCure, a cancer care company, today announced that it is integrating e-prescribing and medication management solutions from health technology…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
/PRNewswire/ – 16 Bit Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted a De Novo marketing authorization for Rhoâ„¢, an…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 51Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis - 9 day(s) ago
− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg)…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software - 9 day(s) ago
/PRNewswire/ — The U.S. Food and Drug Administration granted Sira Medical 510(k) clearance for its augmented reality preoperative surgical planning…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
/PRNewswire/ — Aspen Neuroscience, Inc. announced that the first patient has been dosed in the ASPIRO trial, a Phase 1/2a open label clinical trial to assess…
Source: www.prnewswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 42024 Appian Innovation Award Winners Demonstrate Significant Business Results with Next-Gen AI Process Automation - 10 day(s) ago
/PRNewswire/ — Appian (Nasdaq: APPN) today announced the winners of the 2024 Appian Innovation Awards at its annual global conference, Appian World. Each…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
/PRNewswire/ — Appian (Nasdaq: APPN) today announced immediate availability of the latest version of the Appian Platform. The release introduces the new…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
Invitae Enters into Agreement with Labcorp for Sale of Business 🧬 🧪 https://t.co/voOlnrXlhH